MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 30, 2004; DOI: 10.1124/mol.104.008847


0026-895X/05/6704-1045-1052$20.00
Mol Pharmacol 67:1045-1052, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008847v1
67/4/1045    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruysters, M.
Right arrow Articles by Leurs, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruysters, M.
Right arrow Articles by Leurs, R.
Original Article

Pharmacological Differences between Human and Guinea Pig Histamine H1 Receptors: Asn84 (2.61) as Key Residue within an Additional Binding Pocket in the H1 Receptor

Martijn Bruysters, Aldo Jongejan, Michel Gillard, Frank van de Manakker, Remko A. Bakker, Pierre Chatelain, and Rob Leurs

Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (M.B., A.J., F.v.d.M., R.A.B., R.L.); and UCB S.A. Pharma Sector, Braine-l'Alleud, Belgium (M.G., P.C.)

Abstract

We tested several histamine H1 receptor (H1R) and antagonists for their differences in agonists binding affinities between human and guinea pig H1Rs transiently expressed in African green monkey kidney (COS-7) cells. Especially, the bivalent agonist histaprodifen-histamine dimer (HP-HA) shows a higher affinity for guinea pig than for human H1Rs. Based on the structure of HP-HA, we have further identified VUF 4669 [7-(3-(4-(hydroxydiphenylmethyl)piperidin-1-yl)propoxy)-4-oxochroman-2-carboxylic acid] as a guinea pig-preferring H1R antagonist, demonstrating that the concept of species selectivity is not limited to agonists. To delineate the molecular mechanisms behind the observed species selectivity, we have created mutant human H1Rs in which amino acids were individually replaced by their guinea pig H1R counterparts. Residue Asn84 (2.61) in transmembrane domain (TM) 2 seemed to act as a selectivity switch in the H1R. Molecular modeling and site-directed mutagenesis studies suggest that Asn84 interacts with the conserved Tyr458 (7.43) in TM7. Our data provide the first evidence that for some H1R ligands, the binding pocket is not only limited to TMs 3, 4, 5, and 6 but also comprises an additional pocket formed by TMs 2 and 7.


Received October 29, 2004; accepted December 29, 2004

Address correspondence to: Prof. Dr. R. Leurs, Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. E-mail: r.leurs{at}few.vu.nl




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H.-J. Wittmann, R. Seifert, and A. Strasser
Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor
Mol. Pharmacol., July 1, 2009; 76(1): 25 - 37.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert
Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor
Mol. Pharmacol., March 1, 2009; 75(3): 454 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Strasser, H.-J. Wittmann, and R. Seifert
Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 783 - 791.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Strasser, B. Striegl, H.-J. Wittmann, and R. Seifert
Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 60 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, A. Kraus, P. Ghorai, Q.-Z. Ye, S. Elz, A. Buschauer, and R. Seifert
N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1262 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, P. Ghorai, Q.-Z. Ye, A. Buschauer, and R. Seifert
Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 139 - 146.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics